Cormorant Asset Management, LP Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$1.2T
Holdings
66
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (66 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 2,153,300 | $159.9B | 12.98% | Call |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 1,751,699 | $74.3B | 6.03% | |
| 3 | ANABANAPTYSBIO INC | 1,105,557 | $70.5B | 5.73% | |
| 4 | APLSAPELLIS PHARMACEUTICALS INC | 4,502,498 | $59.4B | 4.82% | |
| 5 | IFRXINFLARX NV | 1,475,140 | $53.7B | 4.36% | |
| 6 | ARGXARGEN SE | 450,000 | $43.2B | 3.51% | |
| 7 | —PRINCIPIA BIOPHARMA INC | 1,474,362 | $40.4B | 3.28% | |
| 8 | RETAEURREATA PHARMACEUTICALS INC | 674,251 | $37.8B | 3.07% | |
| 9 | —DICERNA PHARMACEUTICALS INC | 3,481,471 | $37.2B | 3.02% | |
| 10 | SG7SAGE THERAPEUTICS INC | 367,732 | $35.2B | 2.86% | Put |
| 11 | KZRKEZAR LIFE SCIENCES INC | 1,422,911 | $33.6B | 2.73% | |
| 12 | —MYOKARDIA INC | 677,451 | $33.1B | 2.69% | |
| 13 | —QUOTIENT LTD | 4,762,772 | $29.1B | 2.37% | |
| 14 | RCKTROCKET PHARMACEUTICALS INC | 1,945,659 | $28.8B | 2.34% | |
| 15 | —ZOGENIX INC | 761,395 | $27.8B | 2.25% | Call |
| 16 | NKTREURNEKTAR THERAPEUTICS | 797,000 | $26.2B | 2.13% | Call |
| 17 | —BIOHAVEN PHARMACTL HLDG CO L | 650,000 | $24.0B | 1.95% | |
| 18 | KNSAKINIKSA PHARMACEUTICALS LTD | 831,000 | $23.3B | 1.90% | |
| 19 | TBPHTHERAVANCE BIOPHARMA INC | 884,916 | $22.6B | 1.84% | |
| 20 | —AVROBIO INC | 1,357,784 | $22.6B | 1.84% | |
| 21 | ASNDASCENDIS PHARMA A S | 338,456 | $21.2B | 1.72% | |
| 22 | 2L9BLUEPRINT MEDICINES CORP | 361,351 | $19.5B | 1.58% | |
| 23 | AXNX*AXONICS MODULATION TECH INC | 1,285,828 | $19.4B | 1.58% | |
| 24 | GTHXEURG1 THERAPEUTICS INC | 994,287 | $19.0B | 1.55% | |
| 25 | ZLABZAI LAB LTD | 787,426 | $18.3B | 1.48% | |
| 26 | SLDBSOLID BIOSCIENCES INC | 652,987 | $17.5B | 1.42% | |
| 27 | 1T7TRICIDA INC | 731,621 | $17.3B | 1.40% | |
| 28 | TWSTTWIST BIOSCIENCE CORP | 706,064 | $16.3B | 1.32% | |
| 29 | INCYINCYTE CORP | 251,335 | $16.0B | 1.30% | |
| 30 | NBIXNEUROCRINE BIOSCIENCES INC | 218,222 | $15.6B | 1.27% | |
| 31 | INSPINSPIRE MED SYS INC | 290,239 | $12.3B | 1.00% | |
| 32 | ARNAEURARENA PHARMACEUTICALS INC | 300,000 | $11.7B | 0.95% | |
| 33 | SRPTSAREPTA THERAPEUTICS INC | 90,000 | $9.8B | 0.80% | |
| 34 | AMRNAMARIN CORP PLC | 700,000 | $9.5B | 0.77% | |
| 35 | ARRYEURARRAY BIOPHARMA INC | 580,756 | $8.3B | 0.67% | |
| 36 | —RA PHARMACEUTICALS INC | 441,000 | $8.0B | 0.65% | |
| 37 | ALLKGUSDALLAKOS INC | 150,000 | $7.8B | 0.64% | |
| 38 | KURAKURA ONCOLOGY INC | 550,000 | $7.7B | 0.63% | |
| 39 | ORTXUSDORCHARD THERAPEUTICS PLC | 375,000 | $5.9B | 0.48% | |
| 40 | RUBYUSDRUBIUS THERAPEUTICS INC | 360,910 | $5.8B | 0.47% | |
| 41 | —EIDOS THERAPEUTICS INC | 385,846 | $5.3B | 0.43% | |
| 42 | —CONSTELLATION PHARMACEUTICALS I | 1,271,687 | $5.1B | 0.41% | |
| 43 | SRRKSCHOLAR ROCK HLDG CORP | 210,078 | $4.8B | 0.39% | |
| 44 | REPLREPLIMUNE GROUP INC | 467,792 | $4.7B | 0.38% | |
| 45 | CTMXCYTOMX THERAPEUTICS INC | 296,712 | $4.5B | 0.36% | |
| 46 | —CONTRAFECT CORP | 2,905,638 | $4.4B | 0.36% | |
| 47 | —ARSANIS INC | 1,861,702 | $4.3B | 0.35% | |
| 48 | HRTXHERON THERAPEUTICS INC | 165,682 | $4.3B | 0.35% | |
| 49 | COLLCOLLEGIUM PHARMACEUTICAL INC | 245,370 | $4.2B | 0.34% | |
| 50 | NERVGBPMINERVA NEUROSCIENCES INC | 607,903 | $4.1B | 0.33% | |
| 51 | YMABUSDY MABS THERAPEUTICS INC | 194,768 | $4.0B | 0.32% | |
| 52 | ACRSACLARIS THERAPEUTICS INC | 478,055 | $3.5B | 0.29% | |
| 53 | —ABEONA THERAPEUTICS INC | 488,534 | $3.5B | 0.28% | |
| 54 | —TRANSLATE BIO INC | 454,550 | $3.4B | 0.28% | |
| 55 | —PHASEBIO PHARMACEUTICALS INC | 1,097,926 | $3.4B | 0.28% | |
| 56 | CRSPCRISPR THERAPEUTICS AG | 100,000 | $2.9B | 0.23% | |
| 57 | —AUDENTES THERAPEUTICS INC | 121,797 | $2.6B | 0.21% | |
| 58 | ITRMITERUM THERAPEUTICS PLC | 466,002 | $2.3B | 0.19% | |
| 59 | MGTXMEIRAGTX HOLDGIN PLC | 238,579 | $2.3B | 0.19% | |
| 60 | GBYSANGAMO THERAPEUTICS INC | 194,274 | $2.2B | 0.18% | |
| 61 | XLRNACCELERON PHARMA INC | 48,695 | $2.1B | 0.17% | |
| 62 | OMEROMEROS CORP | 181,700 | $2.0B | 0.16% | Call |
| 63 | QTRXQUANTERIX CORP | 54,945 | $1.0B | 0.08% | |
| 64 | —ARQULE INC | 292,095 | $809.0M | 0.07% | |
| 65 | —OUTLOOK THERAPEUTICS INC | 416,666 | $64.0M | 0.01% | |
| 66 | —CELLECTAR BIOSCIENCES INC | 52,999 | $3.0M | 0.00% |